Cargando…
Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport(®)/Azzalure(®)): Primary Results of the APPEAL Noninterventional Study
BACKGROUND: Although the short- and long-term effectiveness of abobotulinumtoxinA (Dysport(®)/Azzalure(®)) for glabellar line (GL) treatment is well established, reporting of subject satisfaction over repeat treatment cycles is limited. The APPEAL study aimed to assess subject satisfaction with long...
Autores principales: | Gubanova, Elena, Haddad Tabet, May, Bergerova, Yvonne, Moiseieva, Olena, Chemeris, Andrey, Sanches, Elena, Sharova, Alisa, Rodriguez Pose, Luisa, Raymond, Romain, Prygova, Inna, Carlisle, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280832/ https://www.ncbi.nlm.nih.gov/pubmed/30120518 http://dx.doi.org/10.1007/s00266-018-1200-4 |
Ejemplares similares
-
Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport)
por: Dover, Jeffrey S.
Publicado: (2017) -
Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022) -
Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012) -
Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018) -
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
por: Hilton, Said, et al.
Publicado: (2022)